The GCI Dashboard

Version:
Share: whatsapp
Country Rank

15


Bahrain

Recovery Rank for 180 countries/regions

Country Rank

21


Bahrain

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

4

Recovery Index
73.45
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

4

Recovery Index
67.18
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Severity Rating

2

Severity Index
27.29
(Out of 100)



(0 = Best, 100 = Worst)

COVID-19 Severity Rating

4

Severity Index
63.53
(Out of 100)



(0 = Best, 100 = Worst)

Stringency Rating

N/A

(100 = Strictest Measures, 0 = No Measures)


Population
1,641,172

(Very High Density)


GNI per capita (US$)

21,890

(High income)
5 Countries who have made the most progress in
curtailing the spread of the pandemic and can be
used as examples of best practices (Relative Rating)
4
3
2 Countries who are struggling to cope with the crisis
and who may need to consider maintaining stringent
non-pharmaceutical measures (Relative Rating)
1
1 Countries who are coping with the crisis with a low percentage
of infections and resulting deaths per population
(Relative Rating)
2
3 Countries who may be overwhelmed by the crisis with a high
percentage of infections and resulting deaths per population
(Relative Rating)
4
5

Travel Advisory


1. Passengers are not allowed to enter. - This does not apply to: - nationals of Bahrain, Kuwait, Oman, Saudi Arabia and United Arab Emirates; - passengers with a residence permit
issued by Bahrain; - passengers with an e-visa obtained before departure; - passengers who can obtain a visa on arrival; - military personnel; - passengers with: - a COVID-19
vaccination certificate issued in countries that are eligible for visa on arrival; or - a COVID-19 vaccination certificate with a QR code; or - a COVID-19 vaccination certificate
issued in Cyprus, Greece, Hungary, Israel, Jordan Kuwait, Oman, Saudi Arabia, Seychelles or United Arab Emirates. Vaccines accepted are AstraZeneca (SK Bioscience), AstraZeneca
(Vaxzevria), Covishield, Janssen, Moderna (Spikevax), Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac and Sputnik V.

2. Passengers must have a negative COVID-19 PCR test taken at most 48 hours before departure. The test result must have a QR code. - This does not apply to passengers younger than
6 years.

3. Passengers are subject to a COVID-19 PCR test upon arrival. - This does not apply to passengers younger than 6 years.

4. Passengers could be subject to quarantine for up to 10 days. - This does not apply to: - passengers with a COVID-19 vaccination certificate with a QR code showing that they
were fully vaccinated at least 14 days before arrival; - passengers with a COVID-19 vaccination certificate issued in Cyprus, Greece, Hungary, Israel, Jordan Kuwait, Oman, Saudi
Arabia, Seychelles or United Arab Emirates showing that they were fully vaccinated at least 14 days before arrival; - passengers with a COVID-19 vaccination certificate issued in
countries that are eligible for visa on arrival. Vaccines accepted are AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covishield, Janssen, Moderna (Spikevax),
Pfizer-BioNTech (Comirnaty), Sinopharm, Sinovac and Sputnik V.

5. Visa on arrival facility restarted. - This does not apply to passengers with a residence permit issued by Kuwait, Oman, Saudi Arabia or United Arab Emirates, if arriving from a
country other than Kuwait, Oman, Saudi Arabia and United Arab Emirates.

6. Border crossing on the causeway is suspended.

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)

Bahrain Infection Trend


How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.


Countries with Similar Characteristics


This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

Bahrain 67.18 73.45 1,641,172 Very High Density High income 26-30 deg
Country Recovery Index Recovery Index Population Density GNI per capita Average Temperature
since First Case (Celsius)		 Match%
Singapore 46.68 50.11 5,703,569 Very High Density High income 26-30 deg 100%
Hong Kong SAR, China 48.60 7,507,400 Very High Density High income 21-25 deg 85%

GCI Recovery Forecast


The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation May Improve. The GCI Model indicates that the situation has a small probability of recovery, but there is insufficient evidence to suggest that the recovery trend will improve significantly in the near future.




Reviewed and Endorsed by:

In Collaboration and
Partnership with:

image

Recognition and Award:

Chairman's Award



Key Sponsor:

image
image
image